PREVENTION OF IMMUNE PRECIPITATION BY PURIFIED COMPONENTS OF THE ALTERNATIVE PATHWAY
- 1 January 1985
- journal article
- research article
- Vol. 60 (1) , 169-177
Abstract
The role of the alternative pathway in complement-mediated prevention of immune precipitation was investigated by the use of BSA [bovine serum albumin]-anti-BSA immune complex (IC) purified components. For immune precipitation to be prevented all 6 alternative pathway components (C3, factors B D, P, H and I) were reqired. In the absence of one or both of the control proteins H and I, excessive fluid phase turnover of C3 occurred with precipitation of IC. Kinetic studies showed that in the presence of the control proteins, an initial phase of precipitation occurred, and was followed by a phase of resolubilization of IC. When the efficiency of classical and alternative pathways in the prevention of immune precipitation was compared it as found that the classical pathway proteins were more effective than the alternative pathway components. A reaction mixture containing the components of both pathways was no better than the classical pathway protein alone. 125I-C3 was bound to IC which had been rendered soluble in the presence of classical or alternative pathway components. A molar ratio of 2 molecules C3b:5 molecules IgG was calculated. Other complement components which were bound to IC which had been formed in the presence of serum were C1q, C4, C2, C3, C5, P and H. Factors B and I were not detected. Evidently, the alternative pathway is of secondary importance to the classical pathway in the prevention of immune precipitation.This publication has 26 references indexed in Scilit:
- PREVENTION OF IMMUNE PRECIPITATION BY PURIFIED CLASSICAL PATHWAY COMPLEMENT COMPONENTS1984
- Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.The Journal of Experimental Medicine, 1977
- Modulation of the alternative complement pathways by beta 1 H globulin.The Journal of Experimental Medicine, 1976
- Third component of human complement: purification from plasma and physicochemical characterizationBiochemistry, 1976
- The unactivated form of the first component of human complement, C1Biochemical Journal, 1976
- Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.The Journal of Experimental Medicine, 1975
- PROPERDIN FACTOR D: CHARACTERIZATION OF ITS ACTIVE SITE AND ISOLATION OF THE PRECURSOR FORMThe Journal of Experimental Medicine, 1974
- Alternate Complement Pathway: Factors Involved in Cobra Venom Factor (CoVF) Activation of the Third Component of Complement (C3)The Journal of Immunology, 1973
- THE REACTION MECHANISM OF HUMAN C5 IN IMMUNE HEMOLYSISThe Journal of Experimental Medicine, 1970
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965